Literature DB >> 9405685

p53CP, a putative p53 competing protein that specifically binds to the consensus p53 DNA binding sites: a third member of the p53 family?

J Bian1, Y Sun.   

Abstract

p53 tumor suppressor protein negatively regulates cell growth, mainly through the transactivation of its downstream target genes. As a sequence-specific DNA binding transcription factor, p53 specifically binds to a 20-bp consensus motif 5'-PuPuPuC(A/T) (T/A)GPyPyPyPuPuPuC(A/T)(T/A)GPyPyPy-3'. We have now identified, partially purified, and characterized an additional approximately 40-kDa nuclear protein, p53CP (p53 competing protein), that specifically binds to the consensus p53 binding sites found in several p53 downstream target genes, including Waf-1, Gadd45, Mdm2, Bax, and RGC. The minimal sequence requirement for binding is a 14-bp motif, 5'-CTTGCTTGAACAGG-3' [5'-C(A/T)(T/A)GPyPyPyPuPuPuC(A/T)(T/A)G-3'], which includes the central nucleotides of the typical p53 binding site with one mismatch. p53CP and p53 (complexed with antibody) showed a similar binding specificity to Waf-1 site but differences in Gadd45 and T3SF binding. Like p53, p53CP also binds both double- and single-stranded DNA oligonucleotides. Important to note, cell cycle blockers and DNA damaging reagents, which induce p53 binding activity, were found to inhibit p53CP binding in p53-positive, but not in p53-negative, cells. This finding suggested a p53-dependent coordinate regulation of p53 and p53CP in response to external stimuli. p53CP therefore could be a third member of the p53 family, in addition to p53 and p73, a newly identified p53 homolog. p53CP, if sequestering p53 from its DNA binding sites through competitive binding, may provide a novel mechanism of p53 inactivation. Alternatively, p53CP may have p53-like functions by binding and transactivating p53 downstream target genes. Cloning of the p53CP gene ultimately will resolve this issue.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405685      PMCID: PMC25109          DOI: 10.1073/pnas.94.26.14753

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.

Authors:  L R Livingstone; A White; J Sprouse; E Livanos; T Jacks; T D Tlsty
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

2.  Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter.

Authors:  J Bian; Y Sun
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

3.  Affinity purification of sequence-specific DNA binding proteins.

Authors:  J T Kadonaga; R Tjian
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

5.  Structural determinants for transcriptional activation by cAMP-responsive DNA elements.

Authors:  P J Deutsch; J P Hoeffler; J L Jameson; J C Lin; J F Habener
Journal:  J Biol Chem       Date:  1988-12-05       Impact factor: 5.157

6.  Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.

Authors:  U M Moll; G Riou; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

7.  Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

Authors:  Y Yin; M A Tainsky; F Z Bischoff; L C Strong; G M Wahl
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

8.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

Authors:  M B Kastan; Q Zhan; W S el-Deiry; F Carrier; T Jacks; W V Walsh; B S Plunkett; B Vogelstein; A J Fornace
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

9.  Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles.

Authors:  W B Isaacs; B S Carter; C M Ewing
Journal:  Cancer Res       Date:  1991-09-01       Impact factor: 12.701

10.  mdm2 expression is induced by wild type p53 activity.

Authors:  Y Barak; T Juven; R Haffner; M Oren
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

View more
  17 in total

1.  PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway.

Authors:  M Tan; Y Wang; K Guan; Y Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  MDM2 suppresses p73 function without promoting p73 degradation.

Authors:  X Zeng; L Chen; C A Jost; R Maya; D Keller; X Wang; W G Kaelin; M Oren; J Chen; H Lu
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

3.  The p53MH algorithm and its application in detecting p53-responsive genes.

Authors:  J Hoh; S Jin; T Parrado; J Edington; A J Levine; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

4.  E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51 or p73, and cooperate with E4orf6 proteins to destabilize p53.

Authors:  S Wienzek; J Roth; M Dobbelstein
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing.

Authors:  Jun Li; Mingjia Tan; Ling Li; Deepika Pamarthy; Theodore S Lawrence; Yi Sun
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

6.  The N-terminal domain of p73 interacts with the CH1 domain of p300/CREB binding protein and mediates transcriptional activation and apoptosis.

Authors:  X Zeng; X Li; A Miller; Z Yuan; W Yuan; R P Kwok; R Goodman; H Lu
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

Review 7.  p53 and the CNS: tumors and developmental abnormalities.

Authors:  G Fulci; E G Van Meir
Journal:  Mol Neurobiol       Date:  1999-02       Impact factor: 5.590

8.  Non-p53 p53RE binding protein, a human transcription factor functionally analogous to P53.

Authors:  X Zeng; A J Levine; H Lu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

9.  p53-mediated regulation of proliferating cell nuclear antigen expression in cells exposed to ionizing radiation.

Authors:  J Xu; G F Morris
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

10.  p63 induces key target genes required for epidermal morphogenesis.

Authors:  Maranke I Koster; Daisy Dai; Barbara Marinari; Yuji Sano; Antonio Costanzo; Michael Karin; Dennis R Roop
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.